This meeting took place in the past. For a complete list of the meetings for the upcoming/current season, see our meeting list or click on related meetings tab below to check for related meeting(s).
Web Desc
Meeting the Challenges of Drug Discovery
Organizer(s): Stephen W. Fesik and Michael D. Varney
Date: January 15 - 20, 2005
Location: Fairmont Hotel Vancouver, Vancouver, BC, Canada
Sponsored by Iconix Pharmaceuticals, Inc. and ICOS Corporation
Summary of Meeting:
The drug discovery process is difficult, challenging, costly, and often leads to failure. Nevertheless, it is critical that we continue to discover new drugs to meet the many unmet medical needs. To reduce the costs and improve the success of drug discovery and development, new technologies and strategies have been developed. To aid in the target identification and validation steps of the drug discovery process, RNAi technology for gene knockdown is playing an important role along with large-scale gene knockouts in animals. Novel screening approaches, high-throughput synthesis, iterative structure-based design, and in vitro toxicity assays are aiding lead identification and optimization. In addition, approaches are being developed for identifying and utilizing biomarkers in clinical trials to improve the success of drug approval. Advances have also been made in the discovery of biomolecules for the treatment of disease. In this Keystone Symposium, approaches for streamlining and improving drug discovery and development will be discussed that include enabling technologies to aid in target identification/validation and lead identification/optimization, strategies for discovering and applying DNA, RNA, and protein biomarkers in pre-clinical studies and clinical trials, and the use of biologicals to treat disease. In addition, success stories on new drug candidates will be presented.
Discounted Abstract Deadline: September 20 2004
Discounted Registration Deadline: November 15 2004
We gratefully acknowledge additional support for this conference from:
Cell Signaling Technology, Inc.Iconix Biosciences, Inc.ICOS CorporationNovartis Institutes for BioMedical Research
We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:

Abbott Laboratories

Agouron Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

AVEO Pharmaceuticals, Inc.

Bristol-Myers Squibb Company

CeeTox Inc.

Chiron Corporation

Galapagos NV

Genentech, Inc.

Iconix Biosciences, Inc.

ICOS Corporation

Isis Pharmaceuticals, Inc.

Kalypsys, Inc.

Lexicon Pharmaceuticals Inc.

Merck Research Laboratories

Novartis Institutes for BioMedical Research

Odyssey Thera

Ozgene Pty Ltd

SGX Pharmaceuticals

Syrrx, Inc.

Vertex Pharmaceuticals Incorporated
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations

No content found

No content found

No content found

No content found